Silvano Dragonieri Selected Research

Electronic Nose

1/2020	Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
2/2019	Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
1/2017	Electronic Nose Technology in Respiratory Diseases.
11/2016	Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
10/2016	An electronic nose may sniff out amyotrophic lateral sclerosis.
7/2013	An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls.
3/2012	An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
5/2009	An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
10/2007	An electronic nose in the discrimination of patients with asthma and controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvano Dragonieri Research Topics

Disease

12	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 07/2007
6	Asthma (Bronchial Asthma) 08/2021 - 07/2007
4	Obstructive Sleep Apnea 01/2022 - 05/2016
4	Lung Diseases (Lung Disease) 04/2015 - 11/2005
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 07/2013
2	Hypercapnia 06/2022 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 04/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2017
2	Allergic Rhinitis 02/2019 - 09/2007
2	Pulmonary Sarcoidosis 01/2019 - 07/2013
2	Hypoxia (Hypoxemia) 01/2017 - 11/2005
2	Apnea 01/2017 - 01/2016
2	Pulmonary Hypertension 05/2016 - 09/2008
2	Hypertension (High Blood Pressure) 05/2016 - 09/2008
2	Malignant Mesothelioma 03/2012 - 03/2009
1	Down Syndrome (Down's Syndrome) 01/2022
1	COVID-19 10/2021
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2019
1	Disease Progression 12/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2017
1	Atrial Flutter (Flutter, Atrial) 11/2016
1	Pulmonary Arterial Hypertension 11/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2016
1	Dyspnea (Shortness of Breath) 09/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 05/2016
1	Contact Dermatitis (Eczema, Contact) 03/2016
1	Hypersensitivity (Allergy) 03/2016
1	Conjunctivitis 03/2016
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 03/2016
1	Sleepiness 01/2016
1	Chronic Renal Insufficiency 01/2014
1	Sarcoidosis (Schaumann Disease) 07/2013
1	Lung Neoplasms (Lung Cancer) 05/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2009
1	Mesothelioma 03/2009
1	Eosinophilia 09/2007
1	Rhinitis 09/2007
1	Crohn Disease (Crohn's Disease) 11/2005

Drug/Important Bio-Agent (IBA)

5	Volatile Organic CompoundsIBA 11/2020 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2007
2	Galectin 3 (LGALS3)IBA 10/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 02/2019 - 01/2016
2	Bosentan (Tracleer)FDA Link 01/2019 - 11/2016
2	Endothelin-1 (Endothelin 1)IBA 05/2016 - 09/2008
2	AsbestosIBA 03/2012 - 03/2009
1	Carbon DioxideIBA 06/2022
1	S-Adenosylmethionine (Ademetionine)IBA 01/2022
1	Biological ProductsIBA 08/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	SteroidsIBA 01/2019
1	GoldIBA 05/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2017
1	RoflumilastIBA 09/2016
1	Endothelins (Endothelin)IBA 05/2016
1	AllergensIBA 03/2016
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2008
1	EnzymesIBA 09/2008
1	Hypertonic SolutionsIBA 09/2007
1	prednylidene (Pred)IBA 07/2007
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2005

Therapy/Procedure

9	Electronic Nose 01/2020 - 10/2007
6	Therapeutics 06/2022 - 09/2016
3	Noninvasive Ventilation 06/2022 - 01/2014
1	Biological Therapy 08/2021
1	Respiratory Therapy (Therapy, Respiratory) 01/2020
1	Tracheostomy 01/2017
1	Aftercare (After-Treatment) 11/2016
1	Oral Administration 11/2005